Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting1
unknown1
Completed1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

not_yet_recruiting120%
unknown120%
completed120%
recruiting120%
terminated120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Post-Market Study to Assess iTind Safety in Comparison to UroLift

NCT04757116
not_yet_recruitingphase_3

Outcomes of MIST for BPH: A Single-Institution Prospective Study

NCT06275256
unknownnot_applicable

Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH

NCT03395522
completednot_applicable

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

NCT02506465
terminatednot_applicable

Study to Assess the Efficacy, Safety and Tolerability of (iTind)

NCT03239951

Clinical Trials (5)

Showing 5 of 5 trials
NCT04757116Not Applicable

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Recruiting
NCT06275256Phase 3

Outcomes of MIST for BPH: A Single-Institution Prospective Study

Not Yet Recruiting
NCT03395522Not Applicable

Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH

Unknown
NCT02506465Not Applicable

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

Completed
NCT03239951Not Applicable

Study to Assess the Efficacy, Safety and Tolerability of (iTind)

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5